Evidence map›Paper›PMID 39588543›Full record

ArticleFrontiers in psychiatry2024

Imitative inhibitory control is associated with psychotic experiences in a sample from the general population.

José Luis Ulloa, Daniel E Núñez, Pablo A Gaspar, Marcel Brass

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

José Luis UlloaPrograma de Investigación Asociativa (PIA) en Ciencias Cognitivas, Centro de Investigación en Ciencias Cognitivas (CICC), Facultad de Psicología, Universidad de Talca, Talca, Chile.
Daniel E NúñezPrograma de Investigación Asociativa (PIA) en Ciencias Cognitivas, Centro de Investigación en Ciencias Cognitivas (CICC), Facultad de Psicología, Universidad de Talca, Talca, Chile.
Pablo A GasparMillennium Nucleus to Improve the Mental Health of Adolescents and Youths (Imhay), Santiago, Chile.
Marcel BrassBerlin School of Mind and Brain, Humboldt University of Berlin, Berlin, Baden-Württemberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psychotic experiences (PE) are prevalent and associated with several negative mental health outcomes in both clinical and general population, particularly in young people. A promising avenue to understand the mechanisms underlying PE is to investigate functions that may be related to specific neural systems. One of these key cognitive mechanisms is the ability to control our imitative responses, which is strongly linked to an adequate social functioning. Emergent evidence suggests that impairments in this function might be involved in the early expressions of psychosis, but few studies have investigated its association with PE in a sample from the general population. Using an imitation-inhibition paradigm we examined this relationship in a community sample of young healthy individuals (N=204) and found that increased levels of PE levels were associated with lower imitative inhibitory control. These effects seem to be specific to imitation-inhibition as no correlation was found for a more general cognitive control as addressed by a Stroop-like task. In addition, these effects seem to be more evident for paranoid ideations. Overall, our results suggest that imitative inhibitory control can serve as a proxy to detect abnormalities associated with psychotic experiences.

Indexed as

community sampleimitation-inhibitioninhibitory controlonline studypsychotic experiences

Identifiers

PMID39588543
PMCPMC11586380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.